| ID | Type | Location (GRCh37) | Location (GRCh38) | Length | GC content |
|---|---|---|---|---|---|
| hsa_ZEB1_0014000 | Exon-Intron | chr10:31662051-31678624 | chr10:31373122-31389695 | 365 nt | 0.4027 |
| hsa_ZEB1_0014100 | Exon-Exon | chr10:31662051-31750166 | chr10:31373122-31461237 | 396 nt | 0.4268 |
| hsa_ZEB1_0014200 | Exon-Intron | chr10:31662051-31757459 | chr10:31373122-31468530 | 52 nt | 0.3654 |
| hsa_ZEB1_0014300 | Exon-Exon | chr10:31662051-31784767 | chr10:31373122-31495838 | 407 nt | 0.4521 |
| hsa_ZEB1_0014400 | Exon-Exon | chr10:31662051-31791437 | chr10:31373122-31502509 | 58 nt | 0.3448 |
| hsa_ZEB1_0014500 | Exon-Exon | chr10:31663732-31750166 | chr10:31374803-31461237 | 506 nt | 0.4111 |
| hsa_ZEB1_0014600 | Intron-Intron | chr10:31665401-31666452 | chr10:31376472-31377523 | 1052 nt | 0.3298 |
| hsa_ZEB1_0014700 | Intron-Intron | chr10:31668185-31668427 | chr10:31379256-31379498 | 243 nt | 0.3210 |
| hsa_ZEB1_0014800 | Intron-Intron | chr10:31670023-31670461 | chr10:31381094-31381532 | 439 nt | 0.2665 |
| hsa_ZEB1_0015000 | Intron-Intron | chr10:31673662-31674061 | chr10:31384733-31385132 | 400 nt | 0.3625 |
A study in humans identified the circZEB1 as a potential biomarker for immune-mediated demyelinating disease, where its levels in cerebrospinal fluid exosomes were specifically validated [Misir et al. DOI:10.1038/s41418-022-00948-7]. A study in humans demonstrated that circZEB1 was upregulated in left atrial appendages of patients with atrial fibrillation [Tian et al. DOI:10.3390/molecules26041155].